Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

Clinical trial NCT05174052 · RECRUITING

Trial details

NCT number: NCT05174052
Sponsor: University of Oklahoma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Atrial Fibrillation

Start date: 2022-06-01
Primary completion: 2027-04-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.